OneMedNet Corp — Director's Dealing 2025

Nov 27, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OneMedNet Corp (ONMD)
CIK: 0001849380
Period of Report: 2023-11-07

Reporting Person: Yu Jeffrey (Director, Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2455124	Direct
Common Stock	1311970	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Senior Secured Convertible Note	$10.00		Common Stock ()		Direct
Warrants (Right to Buy)	$10.00	2028-11-07	Common Stock (31916)		Direct

Footnotes

F1: The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

F2: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes.

F3: The warrants are immediately exercisable, and the exercise price is subject to anti-dilution adjustment.